ARCHIVES

Weekly Paclitaxel Better Than Every Three Weeks

This article is from The Cancer Letter archive.

Vol. 27 No. 6 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says

February 14, 1992

ASCO Awards Contract For D.C Office

January 12, 1990

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998